TruPharma had 6 potential dossiers with sales totalling US $400...

TruPharma had 6 potential dossiers with sales totalling US $400 million per year but there has been no information on how that’s going since they announced the partnership August(?) or there about’s last year. Same with Amring. 1 potential dossier of which Amring has put US$300,000 towards its development yet no news at all. And this dossier has supposedly sales also of some US$400 million per year. I’m not asking what the products are, just wondering when these dossiers ( if ever) will be submitted to the FDA. Like surely ACR has some idea. Like they say we will be cash flow positive by the end of this year, so they must know something. Or perhaps they don’t.